With the ongoing COVID-19 pandemic, IDI’s Research Programme elected to host the 2nd annual Science Fair (SF) virtually. In keeping with the One IDI culture; a mindset of proactively seeking and creating synergies between the Institute’s programmes, the SF 2021 highlighted individual and collective research contributions towards better health care in resource-limited settings.
The Uganda Minister of Health Rt. Hon. Dr Jane Ruth Aceng accompanied by the WHO Country Representative Dr. Yonas Tegegn Woldemariam and the IDI-Makerere Executive Director, Dr Andrew Kambugu commissioned the Emergency Operation Centre (EOC) at Mbale Regional Referral Hospital
This report labours to going beyond the usual research and patient care-focused aspects of the IDI to show a broader and hopefully more exhilarating aspect of the institute that brings together over 1000 staff to connect with its senior management team, board members, government and development agency stakeholders
With funding from Resolve to Save Lives, IDI Global Health Security program in collaboration with World Health Organisation & Makerere University Water Reed Project supported the training of mentors in Buvuma District in support of Ministry of Health National Action Plan for IPC for COVID-19
IDI renovated the waiting area at Kitebi Health Centre III to create space for research study programmes, increase a spacious environment for counselling, and create harmony for service delivery.
The Health System Strengthening programme handed over two ART facilities at Alwi Health Centre III in Pakwach District and Okollo Health Centre III in Madi Okollo District to the respective district leadership.
IDI held her inaugural Science Fair on 12th February 2020 at the IDI McKinnell Knowledge Centre, Makerere University main campus.
When Dr Andrew Kambugu became the Sande-McKinnell Director of the Infectious Diseases Institute in June of 2018, having received the mantle from Richard Brough, one of his first deeds in office was to a long missive to All Staff about his 15 year IDI journey and his passion to lead the many teams in strengthening health systems.
On Thursday 13th of February, the Core lab under the Laboratory Programme at the Infectious Diseases Institute in Mulago hosted a tour around its facilities in a bid to present its achievements. The tour also presented an opportunity to create awareness of the services offered there and their contribution towards patient safety through quality laboratory service delivery.
The Health Innovations Conference will create opportunities to initiate collaborative efforts in Health Innovation with representatives from the National Institute of Allergy and Infectious Diseases (NIAID), Clarke Group, CryptoSavannah, Case Hospital, Centers for Diseases Control and Prevention (CDC), United States Agency for International Development (USAID), Andela Uganda and Janssen, the Pharmaceutical Companies of Johnson and Johnson. It will be attended by members of various fields such as innovations, health, last mile health and bioinformatics.
On October 3, 2017 in Johannesburg South Africa, the European & Developing Countries Clinical Trials Partnership (EDCTP) launched an Alumni network whose goal is to foster Excellence and Collaboration in the next generation of researchers.
This years’ 9th International Aids Society (IAS) Conference on HIV Science (IAS 2017) is taking place at Palais des Congrès in Paris, France from July 23 to July 26, 2017. It is with great pleasure that I introduce you to the following staff who are representing the Infectious Diseases Institute (IDI), College of Health Sciences, Makerere University at this years’ conference:
On June 28 in Masindi district and on June 29, 2017 in Hoima district, the Infectious Diseases Institute (IDI) organized and held the second Annual Performance Review meeting for its Western Region Comprehensive HIV/AIDS project funded by the Centres for Disease Control and Prevention (CDC).
Tuberculosis (TB) is one of the leading infectious killer diseases worldwide, taking over 1.5 million lives per year. Treatment of TB patients lasts at least six months and can cause serious side effects making it difficult for patients to adhere.